Robert Alexander Ingram, 10% Owner, Director at Clearside Biomedical, Inc. (CLSD), bought 1,727,066 shares at $7.00 ($750K) on 2016-06-07, disclosed to the SEC on 2016-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,598,219 | $0 | 0.0% |
| 2 | $0.02 | 21,705 | $434 | 0.1% |
| 3 | $7.00 | 107,142 | $750K | 99.9% |
| Total | $0.43 avg | 1,727,066 | $750K | 100% |
| Filing → |
| NOVN | BUY | 2019-05-23 | $111K | — | Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |